Related Experiment Video
Updated: May 1, 2026
07:32
Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model
Published on: December 28, 2021
3.6K
Parkinson's disease: recent advances
1Department of Neurology, Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, Donauspital/Danube Hospital, Vienna, Austria, regina.katzenschlager@chello.at.
Journal of Neurology
|April 2, 2014
Summary
While a cure for Parkinson's disease is not yet available, significant advancements have been made in understanding its mechanisms and early symptoms. Current treatments focus on symptom management, including improved options for motor and non-motor complications.
Area of Science:
- Neuroscience
- Neurology
- Movement Disorders
Background:
- Parkinson's disease (PD) understanding has advanced, particularly in early manifestations.
- A definitive disease-modifying treatment for PD remains undiscovered.
- Symptomatic treatments for PD patients have seen considerable improvement.
Purpose of the Study:
- To review current understanding and treatment advancements in Parkinson's disease.
- To highlight progress in managing motor and non-motor symptoms.
- To discuss emerging therapeutic strategies and approaches.
Main Methods:
- Review of recent scientific literature on Parkinson's disease.
- Analysis of advancements in symptomatic treatments.
- Exploration of preclinical and early disease manifestations.
Main Results:
- Improved understanding of Parkinson's disease mechanisms and early signs.
- Enhanced symptomatic treatment options, including invasive therapies like deep brain stimulation.
- Recognition and targeting of non-motor symptoms in treatment trials.
Conclusions:
- While a cure is lacking, Parkinson's disease management has improved significantly.
- Both motor and non-motor aspects of Parkinson's disease are increasingly addressed.
- Future research directions include non-pharmacological and disease-modifying strategies.
Related Concept Videos
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:24Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
01:37Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K